Literature DB >> 22612345

Maternal hypoxia and caffeine exposure depress fetal cardiovascular function during primary organogenesis.

Nobuo Momoi1, Joseph P Tinney, Bradley B Keller, Kimimasa Tobita.   

Abstract

AIMS: Hypoxia is known to influence cardiovascular (CV) function, in part, through adenosine receptor activation. We have shown in a mouse model that during primary cardiac morphogenesis, acute maternal hypoxia negatively affects fetal heart rate, and recurrent maternal caffeine exposure reduces fetal cardiac output (CO) and downregulates fetal adenosine A(2A) receptor gene expression. In the present study, we investigated whether maternal caffeine dosing exacerbates the fetal CV response to acute maternal hypoxia during the primary morphogenesis period.
MATERIAL AND METHODS: Gestational-day-11.5 pregnant mice were exposed to hypoxia (45 s duration followed by 10 min of recovery and repeated 3 times) while simultaneously monitoring maternal and fetal CO using high-resolution echocardiography.
RESULTS: Following maternal hypoxia exposure, maternal CO transiently decreased and then returned to pre-hypoxia baseline values. In contrast to a uniform maternal cardiac response to each exposure to hypoxia, the fetal CO recovery time to the baseline decreased, and CO rebounded above baseline following the second and third episodes of maternal hypoxia. Maternal caffeine treatment inhibited the fetal CO recovery to maternal hypoxia by lengthening the time to CO recovery and eliminating the CO rebound post-recovery. Selective treatment with an adenosine A(2A) receptor antagonist, but not an adenosine A(1) receptor antagonist, reproduced the altered fetal CO response to maternal hypoxia created by caffeine exposure.
CONCLUSIONS: Results suggest an additive negative effect of maternal caffeine on the fetal CV response to acute maternal hypoxia, potentially mediated via adenosine A(2A) receptor inhibition during primary cardiovascular morphogenesis.
© 2012 The Authors. Journal of Obstetrics and Gynaecology Research © 2012 Japan Society of Obstetrics and Gynecology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22612345      PMCID: PMC3427416          DOI: 10.1111/j.1447-0756.2012.01880.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  30 in total

Review 1.  Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology.

Authors:  J C Shryock; L Belardinelli
Journal:  Am J Cardiol       Date:  1997-06-19       Impact factor: 2.778

2.  Expression and pharmacological characterization of a stimulatory subtype of adenosine receptor in fetal chick ventricular myocytes.

Authors:  D Xu; H Y Kong; B T Liang
Journal:  Circ Res       Date:  1992-01       Impact factor: 17.367

Review 3.  Cardiovascular purinoceptors.

Authors:  R A Olsson; J D Pearson
Journal:  Physiol Rev       Date:  1990-07       Impact factor: 37.312

4.  Plasma adenosine responses during repeated episodes of umbilical cord occlusion.

Authors:  K Kubonoya; G G Power
Journal:  Am J Obstet Gynecol       Date:  1997-08       Impact factor: 8.661

5.  The relationship between uterine artery Doppler velocimetry and umbilical venous adenosine levels in pregnancies complicated by preeclampsia.

Authors:  Y Yoneyama; R Sawa; S Suzuki; S Shin; G G Power; T Araki
Journal:  Am J Obstet Gynecol       Date:  1996-01       Impact factor: 8.661

6.  Ontogeny of rat myocardial A1 adenosine receptors.

Authors:  D L Cothran; T R Lloyd; H Taylor; J Linden; G P Matherne
Journal:  Biol Neonate       Date:  1995

7.  Plasma adenosine concentration in appropriate- and small-for-gestational-age fetuses.

Authors:  Y Yoneyama; M Wakatsuki; R Sawa; S Kamoi; H Takahashi; S Shin; T Kawamura; G G Power; T Araki
Journal:  Am J Obstet Gynecol       Date:  1994-02       Impact factor: 8.661

8.  Vascular actions of purines in the foetal circulation of the human placenta.

Authors:  M A Read; A L Boura; W A Walters
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

9.  Adenosine protects ischemic and reperfused myocardium by receptor-mediated mechanisms.

Authors:  M F Janier; J L Vanoverschelde; S R Bergmann
Journal:  Am J Physiol       Date:  1993-01

Review 10.  Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine.

Authors:  B B Fredholm
Journal:  Pharmacol Toxicol       Date:  1995-02
View more
  3 in total

Review 1.  Caffeine and cardiovascular diseases: critical review of current research.

Authors:  Anthony Zulli; Renee M Smith; Peter Kubatka; Jan Novak; Yoshio Uehara; Hayley Loftus; Tawar Qaradakhi; Miroslav Pohanka; Nazarii Kobyliak; Angela Zagatina; Jan Klimas; Alan Hayes; Giampiero La Rocca; Miroslav Soucek; Peter Kruzliak
Journal:  Eur J Nutr       Date:  2016-03-01       Impact factor: 5.614

2.  Maternal Caffeine Consumption during Pregnancy and Risk of Low Birth Weight: A Dose-Response Meta-Analysis of Observational Studies.

Authors:  Jongeun Rhee; Rockli Kim; Yongjoo Kim; Melanie Tam; Yizhen Lai; NaNa Keum; Catherine Elizabeth Oldenburg
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

Review 3.  Validating the Paradigm That Biomechanical Forces Regulate Embryonic Cardiovascular Morphogenesis and Are Fundamental in the Etiology of Congenital Heart Disease.

Authors:  Bradley B Keller; William J Kowalski; Joseph P Tinney; Kimimasa Tobita; Norman Hu
Journal:  J Cardiovasc Dev Dis       Date:  2020-06-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.